IDxSense
- Diagnostics
Pre-company spinout project from the University of Edinburgh seeking seed investment. Company will be formed on the foundation of a patented chemistry platform which allows sensitive and rapid detection of active Granzyme B, a proven biomarker of serious inflammatory disease and tissue damage produced by activated cytotoxic T-Cells. We have proof of concept in acute cellular kidney transplant rejection and inflammatory bowel disease.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}